OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ANNX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Annexon (ANNX) Earnings Date & Reports

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANNX is expected to report earnings to fall 17.49% to -30 cents per share on August 18

Q2'25

Est.

$-0.31

Q1'25

Missed

by $0.07

Q4'24

Missed

by $0.06

Q3'24

Beat

by $0.01

Q2'24

Est.

$-0.23

The last earnings report on May 13 showed earnings per share of -37 cents, missing the estimate of -30 cents. With 390.73K shares outstanding, the current market capitalization sits at 216.14M.

View a ticker or compare two or three

Compare

ANNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ANNX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1400 Sierra Point Parkway

Phone

+1 650 822-5500

Employees

Web

https://www.annexonbio.com